Progress in Three Areas In Breat Cancer Therapy

Article Abstract:

Researchers have recently announced efforts at combating breast cancer. Bristol-Myers Squibb's Taxol combined with doxorubicin and cyclophosphamide has shown promise. Univ. of Washington researchers have developed a vaccine to improve immune systems. Genetech filed a Biologics License Application for Herceptin.

Marketing procedures, Company Planning/Goals, Patents & copyrights, Chemotherapeutic Drugs, Abstract, Antineoplastic agents, Genentech Inc., Bristol-Myers Squibb Co., BMY, GNE, Taxol (Medication), Doxorubicin (Medication), Cyclophosphamide (Medication)

---

Hepatitis C

Article Abstract:

Chronic infection with Hepatitis C virus (HCV) is probably the single most important cause of liver cancer, cirrhosis and chronic liver disease.

Hepatic Preparations, Antiviral agents, Hepatitis

---

Respiratory distress syndrome-life threatening in both adults and infants

Article Abstract:

Article describes various problems which cause lung damage.

Pulmonary Antiinflammatories, Respiratory system agents, Anti-inflammatory agents

Similar abstracts:

• Abstracts: Access to health insurance, barriers to care, and service use among adults with disabilities. Health plan disenrollment in a choice-based Medicaid Managed Care Program
• Abstracts: How to analyze a medical device company. Comparative analysis - health care: products and supplies. Comparative company analysis - healthcare: products and supplies
• Abstracts: Growing pains. The great debate: resolved, PSOs are going to be regulated. The question is, will they get what they want?
• Abstracts: Noteworthy: Respiratory Syncytial Virus (RSV). Gynecological infections--future therapies: plenty of activity and plenty of needs
• Abstracts: From theory to practice: community health nursing in a public health neighborhood team

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.